dobutamine has been researched along with n-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banfor, PN; Campbell, TJ; Cox, BF; Fryer, RM; Marsh, KC; Polakowski, JS; Preusser, LC; Reinhart, GA | 1 |
1 other study(ies) available for dobutamine and n-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide
Article | Year |
---|---|
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
Topics: Acetamides; Animals; Blood Pressure; Calcium; Cardiac Output; Cardiotonic Agents; Cardiovascular System; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hydrazones; Male; Milrinone; Myocardial Contraction; Oxygen Consumption; Potassium; Potassium Channels; Pulmonary Circulation; Pyridazines; Simendan; Time Factors; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 2008 |